<DOC>
	<DOCNO>NCT00801710</DOCNO>
	<brief_summary>This study determine BridgePoint Medical System ( CrossBoss Catheter , Stingray Catheter , Entera Guidewire ) facilitate safe effective placement guidewire true lumen coronary vessel distal chronic total occlusion ( CTO ) . The hypothesis BridgePoint Medical System without increase major complication .</brief_summary>
	<brief_title>CrossBoss Stingray Catheter Entera Guidewire Chronic Total Occlusion ( CTO ) Study</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Suitable coronary intervention de novo restenotic CTO least 3 month old , proximal mid coronary artery segment , 3.05.0 mm diameter Mild/moderate proximal vessel tortuosity Mild/moderate lesion angulation Mild/moderate calcification Satisfactory distal vessel visualization Mild/moderate side branch interference 19 year old BMI &lt; 40 LVEF &gt; 20 % Signed informed consent Extensive dissection guidewire manipulation SVG instent CTO Aortoostial CTO Unable take aspirin , Clopidogrel , Ticlopidine Thrombus/vessel fill defect Severe cerebrovascular disease/stroke within 1 month Intervention within 2 week Renal insufficiency GI bleed Active infection Life expectancy &lt; 2 year Significant anemia Uncontrolled hypertension Severe electrolyte imbalance Anaphylaxis contrast NYHA class IV Unstable angina require intervention MI within 2 week Uncontrolled diabetes Participating another protocol Unwilling/unable comply protocol Angina/ischemia cause target vessel</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>